ResearcherPasteur Institute of IranNo recent work listed

Azam Rajabpour

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-7869-428X; OpenAlex author ID A5062211181.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 2 (first author 2, last author 0)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 2

Papers, trials and grants by year

2017: 2 papers

Papers 2

MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic … First author DOI 10.1007/s00280-017-3418-2 ↗
Molecular alterations contributing to pancreatic cancer chemoresistance. First author DOI 10.1016/j.pan.2016.12.013 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Ladan Teimoori-Toolabi · 2 shared papers, 2017
- Paper Molecular alterations contributing to pancreatic cancer chemoresistance. DOI 10.1016/j.pan.2016.12.013 ↗
- Paper MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced ge… DOI 10.1007/s00280-017-3418-2 ↗
Ali Afgar · 1 shared paper, 2017
- Paper MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced ge… DOI 10.1007/s00280-017-3418-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.